Medication adherence among female inmates with bipolar disorder: Results from a randomized controlled trial

Psychological Services

Volumn 10, Issue 1, 2013, Pages 106-114

  Ehret, Megan J ^a   Shelton, Deborah ^b   Barta, William ^a   Trestman, Robert ^c   Maruca, Annette ^a   Kamath, Jayesh ^c   Golay, Leslie ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Bipolar disorder; Inmates; Medication adherence; TIMA

Indexed keywords

PSYCHOTROPIC AGENT; TRANQUILIZER;

ADOLESCENT; ADULT; ALGORITHM; ARTICLE; BIPOLAR DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; LONGITUDINAL STUDY; MEDICATION COMPLIANCE; MIDDLE AGED; PRISONER; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; SEVERITY OF ILLNESS INDEX; STATISTICS; TIME; TREATMENT OUTCOME; UNITED STATES;

ADOLESCENT; ADULT; ALGORITHMS; ANTIMANIC AGENTS; BIPOLAR DISORDER; CONNECTICUT; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MEDICATION ADHERENCE; MIDDLE AGED; PRISONERS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTROPIC DRUGS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

MLCS; MLOWN;

EID: 84881008188     PISSN: 15411559     EISSN: None     Source Type: Journal    
DOI: 10.1037/a0031433     Document Type: Article

References (30)

1. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders, 4th ed., text rev. Washington, DC: American Psychiatric Association.
2. American Psychiatric Association. (2002). Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psych, 159(Suppl 4), 1-50.
3. Bauer, M. S., Callahan, A. M., Jampala, C., Petty, F., Sajatovic, M., Schaefer, V., . . . Powell, B. J. (1999). Clinical practice guidelines for bipolar disorder from the Department of Veterans Affairs. Journal of Clinical Psychiatry, 60, 9-21.
4. Claxton, A. J., Cramer, J., & Pierce, C. (2001). A systematic review of the associations between dose regimens and medication compliance. Clinical Therapeutics, 23, 1296-1310. doi:10.1016/S0149-2918(01)80109-0
5. Cochran, S. D. (1984). Preventing medical non-compliance in the outpatient treatment of bipolar affective disorders. Journal of Consulting and Clinical Psychology, 52, 873-878. doi:10.1037/0022-006X.52.5.873
6. Crismon, M. L., Argo, T. R., Bendele, S. D., & Suppes, T. (2007). Texas Medication Algorithm Project Procedural Manual. Austin: Texas Department of State Health Services. Available at www.dshs.state.tx.us/mhprograms/pdf/TIMABDman2007.pdf
7. Dennehy, E. P., Suppes, T., Crismon, M. L., Toprac, M., Carmody, T. J., & Rush, A. J. (2004). Development of the Brief Bipolar Disorder Symptom Scale for patients with bipolar disorder. Psychiatry Research, 127, 137-145. doi:10.1016/j.psychres.2004.02.009
8. First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1996). Structured Clinical Interview for Axis I and II DSM-IV Disorders, Patient Edition (SCID-IV/P). New York, NY: Biometrics Research Department, NY State Psychiatric Institute.
9. Frank, A. F., & Gunderson, J. C. (1990). The role of the therapeutic alliance in the treatment of schizophrenia. Archives of General Psychiatry, 47, 228-236. doi:10.1001/archpsyc.1990.01810150028006
10. Freudenberg, N., Daniels, J., Crum, M., Perkins, T., & Richie, B. E. (2005). Coming home from jail: The social and health consequences of community reentry for women, male adolescents and their families and communities. American Journal of Public Health, 95, 1725-1736. doi: 10.2105/AJPH.2004.056325
11. Guy, W. (1976). ECDEU Assessment manual for psychopharmacology: Publication ADM 76-338. Washington, DC: U. S. Department of Health, Education, and Welfare.
12. Hox, J. (2002). Multilevelanalysis techniques & applications. Mahway, NJ: Erlbaum.
13. Jones, S. H., Thornicroft, G., Coffey, M., & Dunni, G. (1995). A brief mental health outcome scale, reliability and validity of the global assessment of functioning (GAF). The British Journal of Psychiatry, 166, 654-659. doi:10.1192/bjp.166.5.654
14. Julius, R. J., Novitsky, M. A., & Dubin, W. R. (2009). Medication adherence: A review of the literature and implications for clinical practice. Journal of Psychiatric Practice, 15, 34 - 44. doi:10.1097/01.pra .0000344917.43780.77
15. Kamath, J., Temporini, H., Quarti, S., Zhang, W., Kesten, K., Wakai, S., . . . Trestman, R. (2010). Disseminating best practices for bipolar disorder treatment in a correctional population. Psychiatric Services, 61, 865-867. doi:10.1176/appi.ps.61.9.865
16. Lamb, H. R., Weinberger, L. E., & Gross, B. H. (1999). Community treatment of severely mentally ill offenders under the jurisdiction of the criminal justice system: A review. Psychiatric Services, 50, 907-913.
17. Martinez-Aran, A., Scott, J., Colom, F., Torrent, C., Tabares-Seisdedos, R., Daban, C., . . . Vieta, E. (2009). Treatment nonadherence and neurocognitive impairment in bipolar disorder. Journal of Clinical Psychiatry, 70, 1017-1023.
18. Mellman, T. A., Miller, A. L., Weissman, E. M., Crismon, M. L., Essock, S. M., & Marder, S. R. (2001). Evidence-based pharmacological treatment for people with severe mental illness: A focus on guidelines and algorithms. Psychiatric Services, 52, 619-625. doi:10.1176/appi.ps.52 .5.619
19. O'Dowd, A. (2006). NICE issues new guidance to improve the treatment of bipolar disorder. British Medical Journal, 333, 220. doi: 10.1136/bmj .333.7561.220
20. Overall, J. E., & Gorham, D. R. (1962). The brief psychiatric rating scale. Psychological Reports, 10, 799-812. doi:10.2466/pr0.1962.10.3.799
21. Rush, A. J., Rago, W. V., & Crismon, M. L. (1999). Medication treatment for the severly and persistently mentally ill: The Texas Medication Algorithm Project. Journal of Clinical Psychiatry, 60, 284-291. doi: 10.4088/JCP.v60n0503
22. Scott, J., & Pope, M. (2002). Nonadherence with mood stabilizers: Prevalence and predictors. Journal of Clinical Psychiatry, 63, 384-390.
23. Smith, L. D. (1989). Medication refusal and the rehospitalized mentally ill inmate. Hospital & Community Psychiatry, 40, 491-496.
24. Suppes, T., Swann, A. C., Dennehy, E. B., Habermacher, E. D., Mason, M., Crismon, M. L., . . . Altshuler, K. Z. (2005). The Texas implementation of medication algorithms: Update to the algorithms for treatment of bipolar I disorder. Journal of Clinical Psychiatry, 66, 870-886.
25. Suppes, T., Dennehy, E. B., Swann, A. C., Bowden, C., Calabrese, J., Hirschfeld, R., . . . Shon, S. P. (2002). Report of the Texas Consensus Conference Panel on medication treatment of bipolar disrder 2000. Journal of Clinical Psychiatry, 63, 288 -299. doi:10.4088/JCP .v63n0404
26. Suppes, T., Swann, A. C., Dennehy, E. B., Habermacher, E. D., Mason, M., Crismon, M. L., . . . Altshuler, K. Z. (2001). Texas Medication Algorithm Project: Development and feasibility testing of a treatment algorithm for patients with bipolar disorder. Journal of Clinical Psychiatry, 62, 439-447. doi:10.4088/JCP.v62n0607
27. Thorburn, K. M. (1995). Health care in correctional facilities. Western Journal of Medicine, 163, 560-564.
28. Velligan, D. I., Weiden, P. J., Sajatovic, M., & Swann, A. C. (2009). The expert consensus guideline series: Adherence problems in patients with serious and persistent mental illness. Journal of Clinical Psychiatry, 70, 1-46.
29. Yatham, L. N., Kennedy, S. H., O'Donovan, C., Parikh, S. V., MacQueen, G., McIntyre, R. S., . . . Beaulieu, S. (2006). Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: Update 2007. Bipolar Disorders, 8, 721-739. doi:10.1111/j.1399-5618.2006.00432.x
30. Yelland, L. N., Salter, A. B., & Ryan, P. (2011). Performance of the modified Poisson Regression Approach for estimating relative risks from clustered prospective data. American Journal of Epidemiology, 174, 984-992. doi:10.1093/aje/kwr183